Armata Pharmaceuticals, Inc.

AMEX: ARMP · Healthcare · Biotechnology

PublicHQ Marina del Rey, CA · Los AngelesCIK 0000921114Reports USD

#1 of 1,422 Healthcare companies by revenue

EA Score

——

FH 27DQ —GM —SS 72

v0.1 · 35/100 weight · pillars only

↑ listing tenure, market scale · ↓ balance-sheet leverage, return on assets

Methodology →

Revenue TTM

$3.3M

Rev growth YoY (TTM)

-52.0%

Net income (FY)

-$173.8M

Employees

as of 2026-08-13

Market cap

$158.2M

as of 2026-08-13

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$173.8M-$173.8M2025

Operating income-$36.6M-$36.6M2025

Total assets$76.9M$76.9M2025

Liabilities$295.5M$295.5M2025

Equity-$218.6M-$218.6M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Armata Pharmaceuticals, Inc.’s financial profile?

Armata Pharmaceuticals, Inc. earned -$173.8M in FY2025 net income.

Peers · Healthcare

Organigram Global Inc.——Conexeu Sciences Inc.——Tenaya Therapeutics, Inc.——Canton Strategic Holdings Inc——Indaptus Therapeutics, Inc.——NervGen Pharma Corp. Common stock——

Neighbors

Los Angeles →

The Walt Disney Company$94.4B72B Public Storage$4.8B80B+Southern California Gas Company PFD SER A 6%——Ares Management Corporation$5.6B68B Live Nation Entertainment, Inc.$25.2B76B+Rocket Lab USA, Inc.$601.8M50D

Key facts

CEODeborah L. Birx

SectorHealthcare

IndustryBiotechnology

HeadquartersMarina del Rey, CA

ExchangeAMEX: ARMP

Employees61

IPO date1994-05-20

Latest filings

10-Q2026-08-12 8-K2026-08-12 8-K2026-07-20 8-K2026-07-20 8-K2026-07-13 8-K2026-06-23 8-K2026-06-16 8-K2026-05-13

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.